TOTAL Spam email never heard of this outfit:
Called Mad Money Alerts!!!! LOLOL this stuff never stops...What a total pump and dump!
Dear MMA Subscribers,
Throughout the month we've been doing nothing but looking at undervalued companies that we think have great potential.
With so many biotech picks having reached new highs on almost a daily or weekly basis we felt it was very important spend time searching for new huge biomedical winners and we believe we’ve found one!
ENTEST BIOMEDICAL, INC ENTB.QB
This company is developing a cancer vaccine that utilizes an encapsulation device as the vaccine delivery system and requires a simple implant procedure that is less invasive than major surgery associated with cancer in canines.
The constant flow of new innovations in biomedicine has several important implications:
· The biomedical supply chain is fulfilled by specialized players (such as our next pick), particularly in the ground-breaking biotech segment.
· While the pharmaceutical and medical device sectors have operated with fairly consistent business models, biomedical models have been evolving constantly, as companies search for the best way to capture the most value from their innovations. Companies have experimented to compete in different spaces within the value chain, from producers of research and tools to full vertical integration.
· The availability of continuous grant funding; from the basic research stage through product development and commercialization, which are crucial in the “trial and error period” of a company.
During the previous round of protocol approvals earlier this year the CEO stated: "This represents a major event for us. Clearing our protocols is the first milestone towards having a viable treatment for canine cancer. Currently, we have begun reviewing patient profiles to prepare for the study's enrollment of dogs that will participate in this treatment. Our goal is to provide a safe treatment for dogs with cancer that is minimally invasive. I have two basset hounds and want to protect their future as well as the future of other pet owners' pets."
There's no limit to the price that ENTB could rise to! Wall Street`s betting big on a genetic technology and we believe ENTB is just beginning to move and just beginning to get recognized by investors!
